Psychopharmacology and Psychiatry Updates

Un pódcast de Psychopharmacology Institute

Categorías:

265 Episodo

  1. Beyond the Pain: Diagnosing Fibromyalgia

    Publicado: 17/5/2024
  2. Informed Consent and SSRIs: Discussing the Risk of Irreversible Sexual Side Effects

    Publicado: 11/5/2024
  3. Mastering Clozapine: Adverse Effect Management

    Publicado: 6/5/2024
  4. Preventing Depression and Anxiety Relapse in Youth

    Publicado: 1/5/2024
  5. Charting the Clozapine Course: Titration and Monitoring

    Publicado: 26/4/2024
  6. Smoking and Psychosis: Insights from the PATH Study

    Publicado: 21/4/2024
  7. Clozapine: The Gold Standard for Treatment-Resistant Schizophrenia

    Publicado: 16/4/2024
  8. Balancing Benefits and Risks: Lithium in Child and Adolescent Psychiatry

    Publicado: 11/4/2024
  9. Orchestrating Nutrition and Medication: Micronutrient Therapy in Practice

    Publicado: 6/4/2024
  10. Zuranolone: A New Dawn for Postpartum Depression Treatment

    Publicado: 1/4/2024
  11. Micronutrients for Psychiatric Disorders: Optimizing Clinical Use

    Publicado: 27/3/2024
  12. Olanzapine in Pregnancy: Examining the Risks

    Publicado: 22/3/2024
  13. Understanding Safety Risks of Broad-Spectrum Micronutrients

    Publicado: 17/3/2024
  14. The Role of Inflammation in Delirium: Can NSAIDs Help?

    Publicado: 12/3/2024
  15. Beyond Medication: Exploring Nutritional Psychiatry

    Publicado: 7/3/2024
  16. Age Impact on Antidepressant Outcomes

    Publicado: 2/3/2024
  17. Dealing With Delirium in Patients With Advanced Cancer

    Publicado: 26/2/2024
  18. Rechallenging Clozapine: A Look at Colony Stimulating Factors

    Publicado: 21/2/2024
  19. Managing Anxiety in Patients With Cancer

    Publicado: 16/2/2024
  20. Managing Antidepressant Side Effects in Youth

    Publicado: 11/2/2024

4 / 14

Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.

Visit the podcast's native language site